The 2 analysts offering 12-month price forecasts for Harvard Bioscience Inc have a median target of 8.50, with a high estimate of 10.00 and a low estimate of 7.00. The median estimate represents a +226.92% increase from the last price of 2.60.
The current consensus among 2 polled investment analysts is to Buy stock in Harvard Bioscience Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.06
Reporting Date Oct 27
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.